EFFICACY, SAFETY AND TOLERABILITY OF RACLOPRIDE, A SPECIFIC D2-RECEPTOR BLOCKER, IN ACUTE SCHIZOPHRENIA - AN OPEN TRIAL
EFFICACY, SAFETY AND TOLERABILITY OF RACLOPRIDE, A SPECIFIC D2-RECEPTOR BLOCKER, IN ACUTE SCHIZOPHRENIA - AN OPEN TRIAL
复制标题
DOI：
10.1097/00004850-198901000-00007
复制
发表时间：
1989-01-01
影响因子：
2.6
通讯作者：
UPPFELDT, G
中科院分区：
文献类型：
--
作者：
COOKSON, JC;NATORF, B;UPPFELDT, G
15例符合DSM-III精神分裂症或类精神分裂症标准的急性患者（男8例，女7例），年龄19 ~ 63岁，参加了为期4周的raclopride开放试验。
Fifteen acutely ill patients (8 male, 7 female) aged 19 to 63 who met DSM-III criteria for schizophrenic disorder or schizophreniform disorder participated in a 4-week open trial of raclopride.